Refractory anemia with excess of blasts
Refractory anemia with excess of blasts | |
---|---|
Classification and external resources | |
ICD-10 | D46.2 |
ICD-9 | 238.73 |
ICD-O | M9983/3 |
MeSH | D000754 |
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome[1] with a marrow blast percentage of 5% to 19%.[2]
In MeSH, "Smoldering leukemia" is classified under RAEB.[3]
References
- ↑ Palmieri S, D'Arco AM, Celentano M et al. (July 2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi:10.1093/annonc/mdl083. PMID 16687417.
- ↑ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood 90 (8): 2969–77. PMID 9376577.
- ↑ Leukemia, Smoldering at the US National Library of Medicine Medical Subject Headings (MeSH)
External links
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
|